Lallemand Health Solutions has gained new indication for its probiotic strain L. paracasei HA-196 from Health Canada recognizing its beneficial effects to help support healthy bowel habits in adults with irritable bowel symptoms (IBS), at a daily dose 10B CFU.
Positive results on quality of life and frequency of bowel movements
This claim is an outcome of recent findings in the gut health area, where L. paracasei HA-196 participated in maintaining a good quality of life in populations with IBS [Lewis, 2020]. This randomized, double-blind, placebo-controlled study performed on 251 North American adults with different IBS subtypes, demonstrated the efficacy of L. paracasei HA-196 to:
- Support quality of life: emotional well-being and social functioning.
- Reduce frequency of bowel movements in IBS-D participants (-21% of spontaneous bowel movement (SBM)) after 8-week intake.
- Increase bowel frequency in IBS-C participants (+33% of SBM) after 8-week intake.
“Another achievement in the documentation of our strains being acknowledged” proudly affirms Solange Henoud, Global Regulatory Affairs Director. “This is the sum of consistent efforts, constant support, and commitment from the Regulatory Affairs, Marketing, Clinical and Scientific Affairs teams”, she adds.
Moreover, L. paracasei HA-196 has also been selected for its complementary action with BiotisTM GOS to create a new bowel support concept. Lallemand Health Solutions and FrieslandCampina Ingredients have recently joined forces to launch best-in-class gut health products combining pre- and probiotics. PRO-Digest Bowel Support has been specifically designed to promote digestive comfort and improve the day-to-day lives of consumers with occasional digestive disturbances. The product contains 10 billion cfu of L. paracasei HA-196 as the research shows improvement of quality of life and a healthier bowel frequency in adults with IBS/IBS-like feelings or events such as occasional diarrhea.
According to the International Foundation for Functional Gastrointestinal Disorders, IBS affects about 10 to 15 percent of the World population. It is twice as common in women as men and typically occurs before age 45 disturbing quality of life by experiences such as occasional abdominal pain, bloating, abdominal distension, constipation (IBS-C) or diarrhea (IBS-D), or both conditions (IBS-M). Learn more about IBS
With over 40 proprietary strains, 600+ formulas, 85 years of know-how, and its own research and development center, Lallemand Health Solutions offers documented probiotic supplements targeting many health segments, including gut health. Its range of Expert’Biotic solutions in this area, show beneficial effects on microflora balance, occasional diarrhea, occasional constipation, and support specific populations from babies to adults.
Marilou Luneau, Content Manager, Lallemand Health Solutions